Characterizing TLR4 agonist EmT4™ as an anti-Mycobacterium tuberculosis vaccine adjuvant.

Immunohorizons · 2025 · PMC12032397 · PMID 40285479

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although a protective trend against M.tb H37Rv was observed in the spleen of the ID93+EmT4TM immunized mice, it did not reach statistical significance ( Fig. 8D ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.